Morari Medical

Executive Summary

Morari Medical is developing MOR, an app-enabled, drug-free wearable skin patch designed to enhance sexual performance by interfering with nerve signals from the penis to the brain. Founded in 2020 and based in San Francisco, the company operates in the medical devices and cardiovascular categories. MOR aims to provide a non-invasive solution for erectile dysfunction and related issues, eliminating the need for pharmaceuticals. The device targets a large market of men seeking safe, discreet alternatives to oral medications. As a private early-stage company, Morari Medical has not disclosed funding or valuation, but its innovative approach positions it well in the growing men's health and digital health sectors. The company faces challenges in regulatory clearance, clinical validation, and market adoption but has potential to disrupt traditional treatments.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance Submission55% success
• Q1 2026Pivotal Clinical Trial Results50% success
• Q2 2026Strategic Partnership for Distribution45% success